Entry |
|
Name |
FGFR3 erdafitinib-susceptible variation
|
Gene |
|
Organism |
hsa_var Human gene variants (Homo sapiens)
|
Variation |
FGFR3-TACC3 fusion, translocation t(4;4)(q16;q16) |
Variation |
FGFR3-BAIAP2L1 fusion, translocation t(4;7)(p16;q22) |
Network |
|
Disease |
|
Drug target |
|
Reference |
|
Authors |
Marandino L, Raggi D, Giannatempo P, Fare E, Necchi A |
Title |
Erdafitinib for the treatment of urothelial cancer. |
Journal |
|
Reference |
|
Authors |
Nadal R, Bellmunt J |
Title |
Management of metastatic bladder cancer. |
Journal |
|
LinkDB |
|